Neurolief Presents Groundbreaking Study Results of its Proliv™Rx Brain Neuromodulation Therapy for Treating Major Depression at the 7th Annual Neuropsychiatric Drug Summit

A New Brain Neuromodulation Therapy Sparks High Interest from Major Pharma Executives TAMPA, Fla., Oct. 8, 2024 /PRNewswire/ — Neurolief, a leading pioneer in neuromodulation technology, recently unveiled its pivotal multicenter RCT clinical study results for its Proliv™Rx brain…